Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10407	Companies
217577	Keywords
147140	Articles
115139	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 06/17/2025 at 07:55, 10 months 27 days ago

EQS-Adhoc: Formycon plans to issue a public senior unsecured floating rate bond with target volume of EUR 50 million to support further company growth
Formycon AG plans EUR 50 million senior unsecured bond issuance for company growth. Joint Lead Managers: IKB Deutsche Industriebank AG, Pareto Securities AS

Formycon AG Bond Issuance EUR 50 Million Senior Unsecured Joint Lead Managers
BRIEF

published on 06/05/2025 at 06:35, 11 months 9 days ago

Le biosimilaire Lucentis® FYB201/Ranivisio® obtient l'approbation au Brésil

Formycon AG Maladies De La Rétine Lucentis® Biosimilaire Approbation Du Brésil Partenariat Biomm
BRIEF

published on 06/05/2025 at 06:35, 11 months 9 days ago

Lucentis® Biosimilar FYB201/Ranivisio® Gains Approval in Brazil

Formycon AG Retinal Diseases Lucentis® Biosimilar Brazil Approval Biomm Partnership
PRESS RELEASE

published on 06/05/2025 at 06:30, 11 months 9 days ago

Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil
Brazil approves Formycon AG's Lucentis biosimilar FYB201/Ranivisio, marking the beginning of Latin America rollout. Commercial partnership with Biomm established

Formycon AG Lucentis Biosimilar Brazil Approval Biomm Partnership Market Rollout
BRIEF

published on 05/27/2025 at 14:35, 11 months 18 days ago

Formycon and Fresenius Kabi Launch Otulfi™ in Canada

Canadian Market Patient Support Ustekinumab Biosimilar Chronic Autoimmune Diseases Biologic Therapies
BRIEF

published on 05/27/2025 at 14:35, 11 months 18 days ago

Formycon et Fresenius Kabi lancent Otulfi™ au Canada

Marché Canadien Soutien Aux Patients Biosimilaire De L'ustekinumab Maladies Auto-immunes Chroniques Thérapies Biologiques
PRESS RELEASE

published on 05/27/2025 at 14:30, 11 months 18 days ago

Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada
Formycon and Fresenius Kabi announce commercial launch of FYB202/Otulfi ustekinumab biosimilar in Canada, expanding treatment options for chronic autoimmune diseases

Canada Formycon Fresenius Kabi Ustekinumab Biosimilar FYB202/Otulfi
BRIEF

published on 05/19/2025 at 15:05, 11 months 26 days ago

Formycon and Fresenius Kabi Achieve FDA Interchangeability Approval for FYB202/Otulfi®

FDA Approval Biosimilars Formycon Fresenius Kabi Otulfi®
BRIEF

published on 05/19/2025 at 15:05, 11 months 26 days ago

Formycon et Fresenius Kabi obtiennent l'approbation d'interchangeabilité de la FDA pour FYB202/Otulfi®

Approbation De La FDA Formycon Fresenius Kabi Biosimilaires Otulfi®
PRESS RELEASE

published on 05/19/2025 at 15:00, 11 months 26 days ago

Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for interchangeability of FYB202/Otulfi (ustekinumab-aauz) with Stelara, enhancing patient access to treatment options for inflammatory diseases in the US

FDA Approval Formycon Fresenius Kabi Biologics Interchangeability

Accesswire

Published on 05/14/2026 at 18:00, 54 minutes ago

AIAI Holdings Corporation Begins Trading on NASDAQ Under Ticker 'AIAI'
Published on 05/14/2026 at 17:10, 1 hour 44 minutes ago

Namibia Critical Metals Announces Results of Annual General Meeting of Shareholders and Issuance of Options
Published on 05/14/2026 at 15:10, 3 hours 44 minutes ago

Banyan Provides Summary of 2025 Diamond Drill Program for the Flagship AurMac Project, Yukon, Canada
Published on 05/14/2026 at 15:00, 3 hours 54 minutes ago

Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 3 hours 54 minutes ago

ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders

View all ACCESSWIRE

EQS Group

Published on 05/14/2026 at 17:05, 1 hour 48 minutes ago

YAS ISLAND TO BE HOME OF SPHERE ABU DHABI, A NEW GLOBAL ICON FOR IMMERSIVE ENTERTAINMENT
Published on 05/14/2026 at 16:55, 1 hour 58 minutes ago

CGTN: 'Constructive strategic stability': China, US eye new vision for ties
Published on 05/14/2026 at 16:15, 2 hours 38 minutes ago

Fibank successfully closed a record-breaking international placement for a Bulgarian bank, raising a total of EUR 310 million across two bond issues
Published on 05/14/2026 at 14:55, 3 hours 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 3 hours 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

Les Echos

Published on 05/14/2026 at 09:03, 9 hours 51 minutes ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 1 day ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 1 day ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires

View all LES ECHOS COMFI WIRE